Study reveals no ‘one-size-fits-all’ balance between solitude and socializing for well-being

Study in Scientific Reports finds no ‘optimal’ balance between solitude and socializing for mental health, suggesting that individual preferences and motivations play a crucial role in well-being.

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’

Pharma giants Novo Nordisk and Eli Lilly might’ve led the way into a new era of obesity drugs, but they’re not going to own it,

September 7, 2023

Santhera fully divests rare eye disease drug Raxone to Chiesi – Pharmaceutical Technology

Santhera expects to maximise the reduced financial burden of the Raxone development programme to focus on vamorolone’s European launch. Credit: MIRCO EMMY / Shutterstock. Santhera

July 31, 2023

Sleep apnea linked to higher hospitalization rates in older adults

A new study to be presented at the SLEEP 2024 annual meeting found that sleep apnea is associated with increased odds of future utilization of

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.